Shanghai Hile Bio-Technology Co., Ltd.

SHSE:603718 Stok Raporu

Piyasa değeri: CN¥4.8b

Shanghai Hile Bio-Technology Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Shanghai Hile Bio-Technology has been growing earnings at an average annual rate of 30.2%, while the Pharmaceuticals industry saw earnings growing at 9% annually. Revenues have been declining at an average rate of 2.8% per year.

Anahtar bilgiler

30.2%

Kazanç büyüme oranı

46.1%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi10.9%
Gelir büyüme oranı-2.8%
Özkaynak getirisi-2.8%
Net Marj-12.5%
Son Kazanç Güncellemesi30 Sep 2024

Yakın geçmiş performans güncellemeleri

There May Be Some Bright Spots In Shanghai Hile Bio-Technology's (SHSE:603718) Earnings

May 06
There May Be Some Bright Spots In Shanghai Hile Bio-Technology's (SHSE:603718) Earnings

Recent updates

Investor Optimism Abounds Shanghai Hile Bio-Technology Co., Ltd. (SHSE:603718) But Growth Is Lacking

Sep 30
Investor Optimism Abounds Shanghai Hile Bio-Technology Co., Ltd. (SHSE:603718) But Growth Is Lacking

There May Be Some Bright Spots In Shanghai Hile Bio-Technology's (SHSE:603718) Earnings

May 06
There May Be Some Bright Spots In Shanghai Hile Bio-Technology's (SHSE:603718) Earnings

Earnings Not Telling The Story For Shanghai Hile Bio-Technology Co., Ltd. (SHSE:603718)

Apr 29
Earnings Not Telling The Story For Shanghai Hile Bio-Technology Co., Ltd. (SHSE:603718)

Gelir ve Gider Dağılımı

Shanghai Hile Bio-Technology nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

SHSE:603718 Gelir, gider ve kazançlar (CNY Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 24230-2913023
30 Jun 24229-411524
31 Mar 242404510724
31 Dec 232416310125
30 Sep 232131938726
30 Jun 2324817310030
31 Mar 2328612512030
31 Dec 2230012212630
30 Sep 223525714731
30 Jun 223505814630
31 Mar 223315113130
31 Dec 213475413529
30 Sep 213313912831
30 Jun 213093312930
31 Mar 213041614229
31 Dec 20259912530
30 Sep 20257-413525
30 Jun 20258-212425
31 Mar 202541210626
31 Dec 192781211130
30 Sep 19275-29534
30 Jun 19285511234
31 Mar 19274712132
31 Dec 182552112127
30 Sep 182617613323
30 Jun 182659212430
31 Mar 1829210913324
31 Dec 1730411414820
30 Sep 173329816913
30 Jun 17334881960
31 Mar 17340822000
31 Dec 16343861940
30 Sep 16330931760
30 Jun 16322941600
31 Mar 16322951520
31 Dec 15317951440
30 Sep 15291921320
30 Jun 152781011160
31 Mar 15278991210
31 Dec 142851011240
31 Dec 133191191180

Kaliteli Kazançlar: 603718 is currently unprofitable.

Büyüyen Kar Marjı: 603718 is currently unprofitable.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 603718 is unprofitable, but has reduced losses over the past 5 years at a rate of 30.2% per year.

Büyüme Hızlandırma: Unable to compare 603718's earnings growth over the past year to its 5-year average as it is currently unprofitable

Kazançlar vs. Sektör: 603718 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-1.2%).


Özkaynak Getirisi

Yüksek ROE: 603718 has a negative Return on Equity (-2.82%), as it is currently unprofitable.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin